Luye Pharma Group Ltd.
Clinical trials sponsored by Luye Pharma Group Ltd., explained in plain language.
A pharmaceutical company focused on innovative drugs and complex formulations.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New pill aims to quiet the constant worry of anxiety disorder
Symptom relief CompletedThis study tests whether a new medication, toludesvenlafaxine, can safely reduce anxiety symptoms in adults with generalized anxiety disorder. Participants receive either a low dose, a high dose, or a placebo pill daily for 8 weeks. The main goal is to see if the drug lowers anxi…
Phase: PHASE3 • Sponsor: Luye Pharma Group Ltd. • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
New drug LY03015 tested for safety in healthy people
Knowledge-focused CompletedThis early-phase trial tested the safety and how the body processes a new drug called LY03015 in 24 healthy adults from Chinese and Caucasian backgrounds. Participants took a single dose and were monitored for about a month. The study is complete and focused on gathering basic sa…
Phase: PHASE1 • Sponsor: Luye Pharma Group Ltd. • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC